Acorda Therapeutics Inc (ACOR.O) Analysts | Reuters.com
Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

25.90USD
2:47pm EDT
Change (% chg)

$0.40 (+1.55%)
Prev Close
$25.50
Open
$25.56
Day's High
$26.24
Day's Low
$25.19
Volume
263,478
Avg. Vol
731,383
52-wk High
$43.63
52-wk Low
$23.85

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 0.22 December 1 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.56 2.56 2.56 2.56

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 9 135.08 140.00 129.46 123.14
Quarter Ending Dec-16 9 140.64 144.50 136.10 125.98
Year Ending Dec-16 10 515.28 534.50 480.00 499.82
Year Ending Dec-17 9 570.99 588.57 539.68 588.49
Earnings (per share)
Quarter Ending Sep-16 6 0.22 0.39 0.09 --
Quarter Ending Dec-16 6 0.27 0.45 0.11 --
Year Ending Dec-16 7 0.74 1.26 0.38 0.93
Year Ending Dec-17 6 0.97 1.36 0.67 0.97
LT Growth Rate (%) 1 29.00 29.00 29.00 37.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 115.36 115.90 0.54 0.47
Quarter Ending Sep-15 115.52 148.20 32.68 28.29
Quarter Ending Mar-15 100.22 99.85 0.37 0.37
Quarter Ending Dec-14 110.76 117.87 7.11 6.42
Quarter Ending Sep-14 94.70 105.96 11.26 11.89
Earnings (per share)
Quarter Ending Mar-16 0.08 0.07 0.01 10.26
Quarter Ending Dec-15 0.22 0.28 0.06 24.83
Quarter Ending Sep-15 0.15 0.31 0.16 110.74
Quarter Ending Jun-15 0.17 0.31 0.14 87.88
Quarter Ending Mar-15 0.14 0.00 0.14 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 135.08 135.08 135.08 135.08 123.14
Quarter Ending Dec-16 140.64 140.64 140.64 140.64 125.98
Year Ending Dec-16 515.28 515.28 515.28 515.30 499.82
Year Ending Dec-17 570.99 570.99 570.99 568.84 588.49
Earnings (per share)
Quarter Ending Sep-16 0.22 0.22 0.22 0.22 --
Quarter Ending Dec-16 0.27 0.27 0.27 0.26 --
Year Ending Dec-16 0.74 0.74 0.74 0.73 0.93
Year Ending Dec-17 0.97 0.97 0.97 0.96 0.97

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Sadif Analytics Prime
$10.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.